Activated PI3K Delta Syndrome (APDS) Latest Advances

Find the Latest Research About Activated PI3K Delta Syndrome (APDS)

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Diagnostic odyssey of patients with the rare immunodeficiency activated PI3 kinase delta syndrome (APDS): case study from expert and patient surveys.

Diagnostic odyssey of patients with the rare immunodeficiency activated PI3 kinase delta syndrome (APDS): case study from expert and patient surveys.

Journal: Frontiers in immunology

Published: December 08, 2025

Phosphoinositide 3-kinase δ activity in patients with systemic lupus erythematosus.

Phosphoinositide 3-kinase δ activity in patients with systemic lupus erythematosus.

Journal: Frontiers in immunology

Published: November 13, 2025

Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?

Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?

Journal: Allergy and asthma proceedings

Published: September 17, 2025

Activated PI3K Delta Syndrome: A Case Presentation and Literature Review.

Activated PI3K Delta Syndrome: A Case Presentation and Literature Review.

Journal: Cureus

Published: August 11, 2025

A rare case report of activated PI3K delta syndrome (APDS): diagnostic pitfalls.

A rare case report of activated PI3K delta syndrome (APDS): diagnostic pitfalls.

Journal: BMC pediatrics

Published: July 31, 2025

Recurrent Macular Vasculitis in Hypergammaglobulinemia as an Underrecognized Presenting Manifestation of Activated PI3K Delta Syndrome.

Recurrent Macular Vasculitis in Hypergammaglobulinemia as an Underrecognized Presenting Manifestation of Activated PI3K Delta Syndrome.

Journal: Pediatric dermatology

Published: July 13, 2025

Spanish Consensus on the Diagnosis and Management of Patients With Activated PI3K Delta Syndrome (APDS).

Spanish Consensus on the Diagnosis and Management of Patients With Activated PI3K Delta Syndrome (APDS).

Journal: Journal of investigational allergology & clinical immunology

Published: March 03, 2025

Recurrent Panuveitis as a Manifestation of a Novel PIK3CD Gene Mutation: A Diagnostic and Management Challenge.

Recurrent Panuveitis as a Manifestation of a Novel PIK3CD Gene Mutation: A Diagnostic and Management Challenge.

Journal: Ocular immunology and inflammation

Published: February 11, 2025

Scalable generation and functional classification of genetic variants in inborn errors of immunity to accelerate clinical diagnosis and treatment.

Scalable generation and functional classification of genetic variants in inborn errors of immunity to accelerate clinical diagnosis and treatment.

Journal: Cell

Published: January 24, 2025

Overlapping Clinical Phenotypes in Patients with Primary Ciliary Dyskinesia or Activated Phosphoinositide 3-Kinase Delta Syndrome.

Overlapping Clinical Phenotypes in Patients with Primary Ciliary Dyskinesia or Activated Phosphoinositide 3-Kinase Delta Syndrome.

Journal: The Journal of pediatrics

Published: December 12, 2024

Refractory marginal zone lymphoma uncovers activated phosphoinositide 3-kinase delta syndrome type 1 (APDS1).

Refractory marginal zone lymphoma uncovers activated phosphoinositide 3-kinase delta syndrome type 1 (APDS1).

Journal: The journal of allergy and clinical immunology. Global

Published: November 29, 2024

Disseminated Ureaplasma urealyticum Infection and Hyperammonemic Encephalopathy in a Patient With Activated PI3K Delta Syndrome 2.

Disseminated Ureaplasma urealyticum Infection and Hyperammonemic Encephalopathy in a Patient With Activated PI3K Delta Syndrome 2.

Journal: Open forum infectious diseases

Published: November 01, 2024

Showing 1-12 of 42

Last Updated: 04/28/2026